Ergosterol-containing fungal membrane

The **ergosterol-containing fungal membrane** refers specifically to the plasma or cellular membranes of fungi that are rich in **ergosterol**, a sterolic lipid unique to fungi and some protozoa. Ergosterol serves many roles analogous to cholesterol in animal cells—it regulates **membrane fluidity**, controls permeability, stabilizes protein distribution within the lipid bilayer, and supports proper function under environmental stress. Its presence is essential for normal growth and survival; disruption leads to loss of viability. Because mammalian cells lack ergosterol—using cholesterol instead—the enzymes involved in its synthesis as well as the molecule itself are prime targets for antifungal therapy. Drugs such as **amphotericin B** bind directly to ergosterol causing lethal pore formation, while azole-class drugs (**fluconazole**, etc.) inhibit its biosynthesis by targeting key enzymes like 14α-demethylase. These mechanisms underpin most modern systemic antifungals. Ergosterol’s critical role also makes it a biomarker for diagnosing invasive fungal infections. However, therapeutic challenges include potential toxicity from some agents—especially polyenes like amphotericin B—and emerging resistance among pathogenic fungi through alterations in sterols or their synthetic pathways.

Other names

Fungal plasma membrane (ergosterol-rich)Fungal cell membrane (ergosterol-containing)Ergosterol-rich membraneFungal sterol membrane

Direct binding to ergosterol in the fungal membrane, forming pores that disrupt ion balance and cause cell death (e.g., amphotericin B). "Amphotericin B... binds physically to ergosterol within the membrane, thus creating a polar pore in fungal membranes. This causes ions... to leak out, which will kill the cell." – Inhibition of ergosterol biosynthesis by blocking enzymes such as 14α-demethylase, leading to defective membranes and impaired growth or death (e.g., azole antifungals like fluconazole).